Skip to main content
 

CSC’s Cancer Policy Institute supports FDA Access to User Fees

Friday, September 20, 2013

On September 10, 2013 the Cancer Support Community’s Cancer Policy Institute sent a letter of thanks and support to those Members of Congress who recently introduced legislation to protect the Food and Drug Administration’s (FDA) user fees from sequestration.

In 2012, Congress passed the FDA Safety and Innovation Act (FDASIA). As a result, new fees – paid by drug and device manufacturers – were instituted to provide the FDA with a much needed funding stream to provide for improvements to their drug and device review processes. This dedicated funding stream was designed to facilitate timely patient access to safe and effective new and generic medicines, medical devices and diagnostics.

What to do When There’s a Drug Shortage

Wednesday, August 7, 2013

In recent years the number of drugs that are in short supply has been increasing, including drugs used to treat cancer. Most of these shortages are for drugs that are injected, or given intravenously. Some of these shortages are short-term and are caused by problems with shipping and ordering. Sometimes these shortages last longer. This is especially true when the shortage is caused by problems in the manufacturing of the drugs. If you have been diagnosed with cancer and are getting chemotherapy as part of your treatment, it is understandable that you would be concerned about a possible drug shortage.